OXFORD BIOTHERAPEUTICS LTD - Profile & Financials

Accounts Submitted 5 Sept 2025

Confirmation Statement Submitted 9 Jun 2025

Net assets £-1.62M £1.53M 2023 year on year

Total assets £16.97M £5.96M 2023 year on year

Total Liabilities £18.58M £4.43M 2023 year on year

Charges 5

5 satisfied

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Suite A, Second Floor, The Schrodinger Building Heatley Road Oxford Science Park Oxford OX4 4GE United Kingdom

Office ()

Oxton, York, United Kingdom, Europe

Office (San Jose Biocenter)

5941 Optical Court, San Jose, CA 95138, USA

Telephone

+1-408-960-7461

info@oxbt.com

Website

oxfordbiotherapeutics.com

Credit Report

Discover OXFORD BIOTHERAPEUTICS LTD's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2023

Type Total Exemption Full

Next accounts 31 December 2024

Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2021–2023)

Cash in Bank

£9.85M

Decreased by £9.15M (-48%)

Net Assets

-£1.62M

Decreased by £1.53M (-1738%)

Total Liabilities

£18.58M

Decreased by £4.43M (-19%)

Turnover

£17.97M

Increased by £3.90M (+28%)

Employees

Debt Ratio

110%

Increased by 10 (+10%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2023 Dec Year End	2022 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share allotments and capital structure

28 Allotments 1,154,746 Shares £3909.26m Total

Date From	Share Class	Shares Allotted	Amount Raised	Price/Share
12 Mar 2025	ORDINARY	2,350	£3k	£1.35
14 Oct 2024	ORDINARY	2,210	£3k	£1.35
14 Oct 2024	ORDINARY	4,000	£11k	£2.86
27 Mar 2024	ORDINARY	4,000	£5k	£1.35
27 Feb 2024	ORDINARY	11,300	£15k	£1.35

Officers

4 active 22 resigned

Show resigned officers

						Status
Bernd Robert Seizinger	Director	German	United States	69	14 Dec 2016	Active
Christian Rohlff	Director	German	United Kingdom	63	11 Dec 2003	Active
Jason Lee Gould	Director	British	England	56	15 Dec 2020	Active
Jean Pierre Bizzari	Director	French,american	United States	71	14 Dec 2016	Active

Shareholders

Shareholders (76)


Wren Capital Nominees Limited	0.6%	30,388	Ordinary	9 Jun 2025
To Uyen Thi Do	0.0%	1,200	Ordinary	9 Jun 2025
Wcs Nominees Limited	0.0%	420	Ordinary	9 Jun 2025

Persons with Significant Control

Persons with Significant Control (3)

3 Active 1 Ceased

South East Growth Fund Managers Limited

United Kingdom

Active

Notified 24 Nov 2018

Nature of Control

Ownership Of Shares 50 To 75 Percent

Gkf Wealth Management Limited

United Kingdom

Active

Notified 24 Nov 2018

Nature of Control

Voting Rights 25 To 50 Percent

Catapult Growth Fund Limited (as Gp For Catapult Growth Fund Limited Partnership)

United Kingdom

Active

Notified 24 Nov 2018

Nature of Control

Ownership Of Shares 25 To 50 Percent

Share Nominees Limited

Ceased 24 Nov 2018

Ceased

See All Controllers

Group Structure

CATAPULT GROWTH FUND LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GKF WEALTH MANAGEMENT LIMITED united kingdom

SOUTH EAST GROWTH FUND MANAGERS LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

CATAPULT ULTIMATE HOLDINGS LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

WEST MIDLANDS ENTERPRISE (INVESTMENTS) LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

WEST MIDLANDS ENTERPRISE LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent

SLINGSHOT BUYOUT LIMITED united kingdom

BW SIPP TRUSTEES LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors, appoint/remove directors as trust, appoint/remove directors as firm

WME GROUP LIMITED united kingdom

BARNETT WADDINGHAM LLP united kingdom significant influence or control limited liability partnership

HOWDEN UK&I HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

HOWDEN BROKING GROUP LIMITED united kingdom voting rights 75 to 100 percent, appoint/remove directors

HGH MIDCO 3 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

HYPERION DEVELOPMENT UK LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

HGH FINANCE LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

HIG FINANCE 2 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

HGH MIDCO 2 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

HGH MIDCO 1 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

HOWDEN GROUP HOLDINGS LIMITED united kingdom

OXFORD BIOTHERAPEUTICS LTD Current Company

Charges

5 satisfied

Documents

Company Filings

Date	Category	Description	Document
29 Oct 2025	Capital	Allotment of shares (GBP 2,967,861.51034) on 2025-09-26	View(5 pages)
5 Sept 2025	Accounts	Annual accounts made up to 2024-12-31	View(39 pages)
9 Jun 2025	Confirmation Statement	Confirmation statement made on 2025-05-27 with updates	View(10 pages)
10 Dec 2024	Capital	Allotment of shares (GBP 2,967,838.01034) on 2024-10-14	View(6 pages)
23 Sept 2024	Accounts	Annual accounts made up to 2023-12-31	View(40 pages)